
Lansoprazole
Lansoprazole delayed-release capsules USP are a proton pump inhibitor (PPI) indicated for: Short-Term Treatment of Active Duodenal Ulcer (1.1) H. pylori. Eradication to Reduce the Risk of…
Lansoprazole delayed-release capsules USP are a proton pump inhibitor (PPI) indicated for: Short-Term Treatment of Active Duodenal Ulcer (1.1) H. pylori. Eradication to Reduce the Risk of…
Leflunomide tablets are indicated for the treatment of adults with active rheumatoid arthritis (RA). Leflunomide is a pyrimidine synthesis inhibitor indicated for the treatment of adults…
Letrozole tablets are an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer (1.1) Extended adjuvant treatment…
Levetiracetam oral solution is indicated for adjunctive therapy in the treatment of: Partial onset seizures in patients one month of age and older with epilepsy (1.1) Myoclonic seizures…
Linezolidis indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Linezolid is not indicated…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2021. All Rights Reserved.